Metabolomics-based treatment for chronic diseases: results from a multidisciplinary clinical study.

Differences at the headache level −2.1% (95% CI: −4.9% to 0.8%, p=0.160) before and after treatment did not reach statistical significance.

also in 111,027 other papers